Peripheral Artery Disease Market Report: Significant Growth Projected Through 2033
Straits Research is pleased to announce the release of its comprehensive report on the global Peripheral Artery Disease (PAD) market. The peripheral artery disease market size was valued at USD 5.22 Billion in 2024. It is projected to reach from USD 5.66 Billion by 2025 to USD 10.75 Billion by 2033, growing at a CAGR of 8.35% during the forecast period (2025–2033).
Market Overview
Peripheral artery disease is characterized by the narrowing or blockage of arteries supplying blood to the limbs, primarily due to atherosclerosis. This condition affects over 200 million adults globally, highlighting an urgent need for effective treatment options and innovations in medical technology. The increasing prevalence of PAD, driven by an aging population and rising rates of chronic diseases such as diabetes and hypertension, is a key factor fueling market growth.
Request a Sample Report of Peripheral Artery Disease Market
Key Drivers of Market Growth
The growth of the PAD market is attributed to several factors:
- Rising Prevalence of PAD: With an increasing number of individuals diagnosed with PAD, the demand for treatment options is surging.
- Technological Advancements: Innovations in minimally invasive procedures and devices are enhancing treatment efficacy and patient outcomes.
- Aging Population: The global demographic shift towards an older population is contributing to a higher incidence of PAD.
- Improved Healthcare Infrastructure: Enhanced healthcare systems, particularly in developing regions, are facilitating better access to treatment.
Segmentation Analysis
The Peripheral Artery Disease market can be segmented based on type, treatment method, disease category, and end-user:
- By Type:
- Peripheral Angioplasty Balloons
- Plaque Modification Devices
- Peripheral Stents
- Peripheral Catheters
- Hemodynamic Flow Alteration Devices
- Inferior Vena Cava (IVC) Filters
- Peripheral Accessories
- By Treatment:
- Devices
- Catheters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Others
- By Disease:
- Lipid Lowering Drugs
- Triple-H Therapy
- Glucose Regulating Drugs
- Blood Clot Preventing Drugs
- Inotropes
- Thrombolytic Agents
- Anti-Inflammatory Agents
- By End User:
- Hospitals & Clinics
- Ambulatory Surgical Clinics
Buy Peripheral Artery Disease Market Report here!
Key Developments in the Market
The report highlights several significant developments within the PAD market:
- Major players are increasingly investing in research and development to innovate new treatments and devices.
- Collaborations between healthcare providers and technology companies are leading to enhanced product offerings.
- Regulatory approvals for advanced medical devices are expected to boost market growth.
Leading Players in the Peripheral Artery Disease Market
Straits Research identifies several top key players driving innovation and competition in the PAD market:
- Abbott Laboratories
- Cardinal Health, Inc.
- Boston Scientific Corporation
- Cook Medical
- Becton Dickinson and Company
- Terumo Corporation
- Koninklijke Philips N.V.
- AngioDynamics, Inc.
- BIOTRONIK
- B. Braun Melsungen AG
These companies are pivotal in shaping the future of PAD treatment through their commitment to quality and innovation.
Browse Full Report and TOC of Peripheral Artery Disease Market
Conclusion
The global Peripheral Artery Disease market is poised for substantial growth over the coming years. The combination of rising prevalence rates, technological advancements, and an aging population presents significant opportunities for stakeholders in this sector.For more detailed insights into the Peripheral Artery Disease market trends and forecasts, please refer to our full report or contact Straits Research directly.
About Straits Research
Straits Research is a leading provider of business intelligence, specializing in research, analytics, and advisory services aimed at delivering comprehensive insights through detailed reports. For further information or inquiries about this press release or our research services, please contact us at sales@straitsresearch.com or call +1 646 905 0080.